PA
COLL icon

Parallel Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Parallel Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.1K Buy
942
+494
+110% +$16.9K ﹤0.01% 2377
2026
Q1 		$14.8K Hold
448
– – ﹤0.01% 2599
2025
Q4 		$20.7K Hold
448
– – ﹤0.01% 2272
2025
Q3 		$15.7K Hold
448
– – ﹤0.01% 2370
2025
Q2 		$13.2K Buy
448
+356
+387% +$10.2K ﹤0.01% 2377
2025
Q1 		$2.75K Buy
92
+82
+820% +$2.51K ﹤0.01% 2880
2024
Q4 		$287 Sell
10
-39
-80% -$1.29K ﹤0.01% 3325
2024
Q3 		$1.89K Buy
49
+37
+308% +$1.32K ﹤0.01% 2907
2024
Q2 		$386 Buy
+12
New +$416 ﹤0.01% 3125
2022
Q1 		– Sell
-15
Closed – – 3012
2021
Q4 		$0 Buy
+15
New +$292 ﹤0.01% 3113

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Parallel Advisors's COLL Position: Q2 2026 in Review

Parallel Advisors increased its Collegium Pharmaceutical (COLL) stake by 110% in Q2 2026, buying an estimated $16.9K and bringing the position to 942 shares worth $34.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2377.

Parallel Advisors first reported a position in COLL in Q4 2021 and has held it in 10 quarters since. 204 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Parallel Advisors held 942 shares of Collegium Pharmaceutical worth $34.1K as of Q2 2026.
  • Parallel Advisors bought 494 Collegium Pharmaceutical shares in Q2 2026, an estimated $16.9K.
  • Collegium Pharmaceutical made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2377 holding.
  • Parallel Advisors first reported a position in Collegium Pharmaceutical in Q4 2021 and has held it in 10 quarters since.
  • 204 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.